SBIR/STTR Research Award
Contrast Agents for Far Red and Near Infrared Imaging
Award amount
$0Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PTI RESEARCH, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Provided by Applicant): Tools to monitor immune cell interactions
and their consequences will accelerate development of successful
immunotherapies for cancer, HIV disease, and autoimmune disorders. High levels
of autofluorescence and spectral overlap limit use of stable fluorescent labels
for cell proteins or membranes with other visible probes. High levels of tissue
absorption and scattering preclude real time optical imaging in intact animals.
PTIR has synthesized five new cell tracking dyes fluorescing in the 667-837 nm
range (far red - near infrared). S/N for labeled cells were up to 15x of those
for PKH26; spectral overlap properties were suitable for use with many other
fluorescent probes; and feasibility criteria for chemical stability,
photostability, and lack of effect on cell viability and growth were met.
Labeled cells were also readily imaged in superficial lung microvessels using
intact organ microscopy and at subcutaneous injections sites in nude mice,
attesting to the potential for noninvasive, whole body imaging.
In Phase II PTIR will develop two kits f or preclinical use and screening and
initiate studies to support a clinical cell tracking dye. The first kit will be
for standard 3-4 color instruments, the second for high-end instrumentation.
Our collaborators will evaluate both kits by monitoring proliferation of
lymphocyte subsets, determining the depth to which tumor cells can be tracked
in intact lung preparations from rats, and determining the minimum number of
cells which can be imaged at deep vs. superficial sites in intact animals.
PROPOSED COMMERCIAL APPLICATION:
Membrane labeling dyes emitting in the far red or near infrared have significant commercial potential in three markets; 1) a research market serving both basic and clinical investigators
using flow cytometers; 2) a similar and rapidly growing market in optical imaging, especially
intact organ or whole body imaging; and for molecules with suitable photochemical
properties, 3) photodiagnosis and/or phototherapy.
Technology keywords
Not reported